Arrowhead Pharmaceuticals Inc (ARWR)
18.54
+0.26
(+1.42%)
USD |
NASDAQ |
Nov 22, 16:00
18.53
-0.01
(-0.05%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0243 |
| June 30, 2018 | 0.0232 |
| March 31, 2018 | 0.0213 |
| December 31, 2017 | 0.0351 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0311 |
| June 30, 2017 | 0.0287 |
| March 31, 2017 | 0.028 |
| December 31, 2016 | 0.0274 |
| September 30, 2016 | 0.0285 |
| June 30, 2016 | 0.0455 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.0003 |
| June 30, 2014 | 0.0003 |
| March 31, 2014 | 0.0055 |
| December 31, 2013 | 0.0127 |
| September 30, 2013 | 0.0371 |
| June 30, 2013 | 0.0279 |
| March 31, 2013 | 0.1751 |
| December 31, 2012 | 0.1098 |
| September 30, 2012 | 0.0938 |
| June 30, 2012 | 0.0847 |
| March 31, 2012 | 0.0611 |
| December 31, 2011 | 0.0435 |
| September 30, 2011 | 0.0474 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
--
Maximum
Dec 2019
--
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| Vaxcyte Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.9382 |
| IGC Pharma Inc | 0.0183 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 883.76M |
| Total Liabilities (Quarterly) | 544.78M |
| Shareholders Equity (Quarterly) | 330.55M |